Summary

Market Overview
The Global Western Blotting Market was valued at USD 1.98 billion in 2024 and is projected to reach USD 2.84 billion by 2030, growing at a CAGR of 6.20% during the forecast period. The market is being driven by continued advancements in biomedical technology and an increase in government funding for life sciences research. The rising adoption of personalized medicine for chronic disease diagnosis and the global burden of infectious diseases like HIV are also boosting demand for western blotting techniques. For instance, in 2021, approximately 38.4 million people were living with HIV globally, with 1.5 million new infections reported, contributing to heightened diagnostic testing needs. These trends are significantly enhancing the adoption of western blotting across diagnostic and research laboratories worldwide.
Key Market Drivers
Rising Incidence of Chronic and Infectious Diseases
The increasing occurrence of chronic illnesses, such as cancer, autoimmune disorders, and neurodegenerative diseases, is fueling the demand for precise diagnostic techniques like western blotting. Known for its high specificity and sensitivity, western blotting is critical in detecting and quantifying proteins, making it an essential tool in clinical diagnostics and biomedical research. With chronic conditions responsible for over 70% of global deaths, according to WHO, and infectious diseases like HIV and Lyme disease still prevalent, the need for reliable confirmation tests is growing.
Western blotting is often used when ELISA tests return inconclusive results, particularly in the detection of antibodies and antigens. Government initiatives focusing on infectious disease control, such as national HIV/AIDS programs, often incorporate western blotting, further driving its market expansion. Increased investments in diagnostic infrastructure and public health efforts continue to support the demand for this vital analytical method.
Key Market Challenges
High Cost and Complexity of Western Blotting Procedures
Despite its diagnostic value, western blotting remains a time-consuming and technically demanding technique. It involves multiple stages, including electrophoresis, protein transfer, and antibody detection, all of which require skilled professionals and high-quality materials. The cost of antibodies, imaging systems, and reagents adds to the overall expense, posing a challenge for labs with limited funding, especially in low-resource settings.
Smaller institutions and healthcare facilities may struggle to maintain the infrastructure and budget necessary for routine use of western blotting. Budget constraints and the risk of procedural errors or contamination can result in repeat testing, increasing the operational burden. As a result, some organizations may opt for simpler or more cost-effective diagnostic alternatives, which could restrain the broader adoption of traditional western blotting systems.
Key Market Trends
Automation and Integration of Western Blotting Workflows
A major trend in the western blotting market is the shift toward automation and integrated platforms. Manual western blotting involves several labor-intensive and time-consuming steps that can introduce variability. In response, manufacturers are launching automated systems that streamline the entire process from sample preparation to detection and image analysis.
These automated systems improve reproducibility, reduce human error, and enhance throughput, making them highly appealing for both research and clinical settings. Government-funded initiatives, such as the European Union’s Horizon 2020 program, have promoted the adoption of digital and automated solutions in life sciences, supporting the uptake of such technologies. Automated platforms often feature user-friendly software, cloud-based storage, and multiplexing capabilities, aligning with broader trends of digitization and efficiency in diagnostics. As laboratories aim to handle increasing sample volumes with improved accuracy, automation is becoming a key differentiator in the western blotting landscape.
Key Market Players
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• EMD Millipore Corporation
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• LI-COR, Inc.
• Bio-Techne Corporation
• QIAGEN N.V.
• Advansta Inc.
Report Scope:
In this report, the Global Western Blotting Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Western Blotting Market, By Product:
 o Instruments
 o Consumables
• Western Blotting Market, By Application:
 o Biomedical Biochemical Research
 o Disease Diagnostics
 o Agriculture
 o Food & Beverages
 o Other Applications
• Western Blotting Market, By End User:
 o Diagnostic Laboratories
 o Research Institutions
 o Pharmaceutical & Biotechnology Companies
• Western Blotting Market, By Region:
 o North America
  § United States
  § Mexico
  § Canada
 o Europe
  § France
  § Germany
  § United Kingdom
  § Italy
  § Spain
 o Asia-Pacific
  § China
  § India
  § South Korea
  § Japan
  § Australia
 o South America
  § Brazil
  § Argentina
  § Colombia
 o Middle East and Africa
  § South Africa
  § Saudi Arabia
  § UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Western Blotting Market.
Available Customizations:
Global Western Blotting Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Western Blotting Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Consumables)
5.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
5.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2024)
5.3. Market Map
5.3.1 By Product
5.3.2 By Application
5.3.3 By End User
5.3.4 By Region
6. North America Western Blotting Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Instruments, Consumables)
6.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
6.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Western Blotting Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Western Blotting Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Western Blotting Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Western Blotting Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Instruments, Consumables)
7.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
7.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Western Blotting Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Western Blotting Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Western Blotting Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Western Blotting Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Western Blotting Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Western Blotting Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Instruments, Consumables)
8.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
8.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Western Blotting Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Western Blotting Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Western Blotting Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Western Blotting Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Western Blotting Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Western Blotting Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Instruments, Consumables)
9.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
9.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Western Blotting Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Western Blotting Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Western Blotting Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Western Blotting Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Instruments, Consumables)
10.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
10.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Western Blotting Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.1.2.4.
10.3.2. Saudi Arabia Western Blotting Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Western Blotting Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Western Blotting Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Thermo Fisher Scientific Inc.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. F. Hoffmann-La Roche Ltd.
15.3. Danaher Corporation
15.4. EMD Millipore Corporation.
15.5. Bio-Rad Laboratories, Inc.
15.6. PerkinElmer Inc.
15.7. LI-COR, Inc.
15.8. Bio-Techne Corporation
15.9. QIAGEN N.V.
15.10. Advansta, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer